(Q43595663)

25 November 2017

title

Influence of menopausal status in homocysteine plasma levels (English)

1 reference

25 November 2017

Fernández-Miranda C

1

1 reference

25 November 2017

de la Calle M

2

1 reference

25 November 2017

Manuel Bris J

3

1 reference

25 November 2017

Muelas M

4

1 reference

25 November 2017

Gómez P

5

1 reference

25 November 2017

Díaz-Rubio P

6

1 reference

25 November 2017

publication date

1 February 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

116

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

206-208

1 reference

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Plasma homocysteine levels and mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Folic acid responsive postmenopausal homocysteinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Plasma homocysteine and menopausal status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Increased plasma homocysteine after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

The effect of reduced glomerular filtration rate on plasma total homocysteine concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Homocysteine and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

Homocysteine and risk of cardiovascular disease among postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971772-1

10.1016/S0025-7753(01)71772-1

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference